1. Home
  2. MODV vs CASI Comparison

MODV vs CASI Comparison

Compare MODV & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MODV
  • CASI
  • Stock Information
  • Founded
  • MODV 1996
  • CASI 1991
  • Country
  • MODV United States
  • CASI China
  • Employees
  • MODV N/A
  • CASI N/A
  • Industry
  • MODV Transportation Services
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MODV Consumer Discretionary
  • CASI Health Care
  • Exchange
  • MODV Nasdaq
  • CASI Nasdaq
  • Market Cap
  • MODV 43.6M
  • CASI 37.6M
  • IPO Year
  • MODV N/A
  • CASI 1996
  • Fundamental
  • Price
  • MODV $0.43
  • CASI $2.44
  • Analyst Decision
  • MODV Buy
  • CASI Strong Buy
  • Analyst Count
  • MODV 4
  • CASI 1
  • Target Price
  • MODV $9.17
  • CASI $4.00
  • AVG Volume (30 Days)
  • MODV 18.7M
  • CASI 3.7M
  • Earning Date
  • MODV 09-09-2025
  • CASI 09-09-2025
  • Dividend Yield
  • MODV N/A
  • CASI N/A
  • EPS Growth
  • MODV N/A
  • CASI N/A
  • EPS
  • MODV N/A
  • CASI N/A
  • Revenue
  • MODV $2,753,789,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • MODV N/A
  • CASI N/A
  • Revenue Next Year
  • MODV $4.90
  • CASI N/A
  • P/E Ratio
  • MODV N/A
  • CASI N/A
  • Revenue Growth
  • MODV N/A
  • CASI 8.39
  • 52 Week Low
  • MODV $0.40
  • CASI $1.09
  • 52 Week High
  • MODV $32.82
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • MODV 24.83
  • CASI 58.82
  • Support Level
  • MODV $0.55
  • CASI $2.27
  • Resistance Level
  • MODV $1.46
  • CASI $2.59
  • Average True Range (ATR)
  • MODV 0.26
  • CASI 0.31
  • MACD
  • MODV -0.19
  • CASI 0.01
  • Stochastic Oscillator
  • MODV 1.39
  • CASI 41.89

About MODV ModivCare Inc.

ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: